Drug survival of thalidomide for dermatological conditions: A single-centre review

Australas J Dermatol. 2021 Feb;62(1):e107-e109. doi: 10.1111/ajd.13384. Epub 2020 Jul 6.

Authors

Alexis Arasu¹, Senhong Lee², Aun Chian Yeoh¹, Gayle Ross³

Affiliations

¹ Monash Health, Clayton, Victoria, Australia.
² Department of Dermatology, Northern Health, Epping, Victoria, Australia.
³ Department of Dermatology, St Vincent's Hospital, Fitzroy, Victoria, Australia.

PMID: 32627846
DOI: 10.1111/ajd.13384

No abstract available

Publication types

Letter

MeSH terms

Dermatologic Agents / adverse effects
Dermatologic Agents / therapeutic use*
Humans
Prurigo / drug therapy
Skin Diseases / drug therapy*
Stomatitis, Aphthous / drug therapy
Thalidomide / adverse effects
Thalidomide / therapeutic use*

Substances

Dermatologic Agents
Thalidomide